What the Restasis TV commercial is about.
Restasis is a prescription medication designed to treat chronic dry eye syndrome. The Restasis TV spot is a commercial that advertises the benefits of using this medication to relieve the symptoms of dry eye syndrome.
The commercial typically features a woman who is struggling with dry, irritated eyes. She talks about how it affects her daily life, making it difficult to work, read, or even drive. She then tells the viewer that there is hope with Restasis.
The commercial then goes on to explain how Restasis works, which is by increasing the production of natural tears in the eyes. The woman in the commercial describes how using Restasis has improved her life, and she encourages viewers who suffer from dry eyes to talk to their doctor about whether Restasis is right for them.
Overall, the Restasis TV spot aims to educate viewers about the benefits of using this medication to alleviate the discomfort caused by chronic dry eye syndrome. It highlights the effectiveness of Restasis and encourages sufferers to seek help from their doctor to improve their quality of life.
Restasis TV commercial produced for
Restasis
was first shown on television on July 30, 2012.
Frequently Asked Questions about restasis tv spot
Allergan, Inc., an AbbVie company, is providing this information to help patients find physicians in their area who have experience with RESTASIS®. No fees have been received by Allergan, Inc., an AbbVie company, or paid to the physicians for their inclusion in this locator directory.
RESTASIS® was developed specifically to treat a type of Chronic Dry Eye with decreased tear production due to inflammation. It can help increase the eyes' natural tear production with time and consistent use. In a study, patients using RESTASIS® saw an increase in tear production at 6 months.
However, one common cause for higher consumer cost is a lack of competition. Restasis is a brand-name drug. These drugs are often under patent when first released, meaning no one else can manufacture them. So they are frequently priced higher initially due to a lack of similar medications vying for the same market.
Is anyone else creeped out by the ethereal lady eye doctor on the Restasis commercials? Her name is Dr. Alison Tendler, a board-certified ophthalmologist in South Dakota, a real doctor, not an actress, so I cut her some slack.
Restasis has an average rating of 4.5 out of 10 from a total of 190 reviews for the treatment of Dry Eye Disease. 26% of reviewers reported a positive experience, while 50% reported a negative experience.
Official answer. Yes, Restasis (cyclosporine ophthalmic emulsion) is safe for long-term use, and the potential side effects are the same regardless of how long the therapy is used.
Restasis® has U.S. Food and Drug Administration (FDA) approval to treat eye inflammation due to dry eye disease (keratoconjunctivitis sicca). It can also treat inflammation and dry eye that happen on their own or because of another condition like allergic eye irritation or Sjögren's syndrome.
In general, patients are advised to use Restasis for a minimum of 6 months, with the understanding that the vast majority will require lifelong treatment to remain symptom-free. Side effects were similar in 1-year and 3-year trials.
The RESTASIS® list price, also known as the wholesale acquisition cost (WAC), 1 iS $645.63 † for a 30-day supply of RESTASIS® or RESTASIS MultiDose®. Call 1.844. 4MY-TEARS (1-844-469-8327) to find how much RESTASIS® will cost for you.
Restasis is meant to be used as a long-term treatment. If you and your doctor determine that Restasis is safe and effective for you, you'll likely take it long term.
Xeomin TV Spot, 'Beauty On Your Terms' Featuring Teyana Taylor - iSpot.tv.
Jeong, a one-time doctor turned actor-comedian, said he has suffered from dry eye disease for decades. Ken Jeong has made a career joking around about a lot of things, but dry eye disease is not one of them.